Quarterly Result11 Aug 2026, 01:38 pm
Fermenta Biotech Q1FY27 Revenue ₹126.2 Cr; PAT Down 56% YoY
AI Summary
Fermenta Biotech Ltd reported unaudited Q1FY27 consolidated revenue of INR 126.2 crore, flat quarter-on-quarter (QoQ) and down 13% year-on-year (YoY). EBITDA stood at INR 22.4 crore, down 39% YoY and 11% QoQ. Profit After Tax (PAT) declined significantly by 56% YoY to INR 9.5 crore, impacted by non-recurring items in the previous year's comparable quarter. Human nutrition volumes saw an 18% QoQ increase, and the Indian market's contribution rose to 47% of consolidated revenue. The company highlighted growth in Other APIs and Intermediates, and Green Chemistry Solutions/Enzymes.
Key Highlights
- Consolidated revenue at ₹126.2 Cr, flat QoQ and down 13% YoY.
- PAT down 56% YoY to ₹9.5 Cr due to prior year's non-recurring income.
- Human nutrition volumes up 18% QoQ; India revenue share increased to 47%.
- Other APIs and Green Chemistry Solutions showed YoY growth.
- Vitamin D3 - Animal Nutrition segment faced significant YoY decline.
Price Impact
More from FERMENTA